Skip to main content
. 2021 Jul 30;12:4636. doi: 10.1038/s41467-021-24906-y

Table 2.

Number of participants reporting local and systemic solicited AEs.

ChAdOx1 Chik 5 × 109 vp (n = 6) ChAdOx1 Chik 2.5 × 1010 vp (n = 9) ChAdOx1 Chik 5 × 1010 vp (n = 9)
Any Mild Moderate Severe Any Mild Moderate Severe Any Mild Moderate Severe
Any symptom 4 (67%) 4 (67%) 0 0 9 (100%) 6 (67%) 3 (33%) 0 9 (100%) 4 (44%) 3 (33%) 2 (22%)
Any local symptom 3 (50%) 3 (50%) 0 0 9 (100%) 8 (89%) 1 (11%) 0 7 (78%) 5 (56%) 2 (22%) 0
Pain 3 (50%) 3 (50%) 0 0 9 (100%) 8 (89%) 1 (11%) 0 7 (78%) 5 (56%) 2 (22%) 0
Pruritus 0 0 0 0 0 0 0 0 0 0 0 0
Warmth 0 0 0 0 4 (44%) 4 (44%) 0 0 3 (33%) 3 (33%) 0 0
Swelling 0 0 0 0 0 0 0 0 0 0 0 0
Erythema 0 0 0 0 0 0 0 0 1 (11%) 1 (11%) 0 0
Any systemic symptom 2 (33%) 2 (33%) 0 0 9 (100%) 6 (67%) 3 (33%) 0 9 (100%) 4 (44%) 3 (33%) 2 (22%)
Fever 0 0 0 0 2 (22%) 2 (22%) 0 0 2 (22%) 2 (22%) 0 0
Feverishness 1 (17%) 1 (17%) 0 0 6 (67%) 3 (33%) 3 (33%) 0 7 (78%) 4 (44%) 2 (22%) 1 (11%)
Arthralgia 0 0 0 0 3 (33%) 3 (33%) 0 0 4 (44%) 0 3 (33%) 1 (11%)
Myalgia 1 (17%) 1 (17%) 0 0 7 (78%) 6 (67%) 1 (11%) 0 6 (67%) 2 (22%) 3 (33%) 1 (11%)
Headache 1 (17%) 1 (17%) 0 0 7 (78%) 6 (67%) 1 (11%) 0 6 (67%) 3 (33%) 1 (11%) 2 (22%)
Fatigue 2 (33%) 2 (33%) 0 0 5 (56%) 5 (56%) 0 0 8 (89%) 4 (44%) 4 (44%) 0
Nausea 0 0 0 0 2 (22%) 1 (11%) 1 (11%) 0 3 (33%) 1 (11%) 2 (22%) 0
Malaise 1 (17%) 1 (17%) 0 0 6 (67%) 6 (67%) 0 0 5 (56%) 1 (11%) 3 (33%) 1 (11%)